Find Evocalcet manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 870964-67-3, Evocalcet [inn], Mt-4580, Khk-7580, Khk7580, E58mlh082p
Molecular Formula
C24H26N2O2
Molecular Weight
374.5  g/mol
InChI Key
RZNUIYPHQFXBAN-XLIONFOSSA-N
FDA UNII
E58MLH082P

Evocalcet
Evocalcet is an orally available calcium receptor (CaR) modulator, with potential calcimimetic activity. Upon administration, evocalcet allosterically binds to and inhibits the activity of CaR, thereby suppressing the production of serum parathyroid hormone (PTH) and prevents the PTH-mediated efflux of calcium from bone and normalizes calcium levels.
1 2D Structure

Evocalcet

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[(3S)-3-[[(1R)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic acid
2.1.2 InChI
InChI=1S/C24H26N2O2/c1-17(22-8-4-6-19-5-2-3-7-23(19)22)25-20-13-14-26(16-20)21-11-9-18(10-12-21)15-24(27)28/h2-12,17,20,25H,13-16H2,1H3,(H,27,28)/t17-,20+/m1/s1
2.1.3 InChI Key
RZNUIYPHQFXBAN-XLIONFOSSA-N
2.1.4 Canonical SMILES
CC(C1=CC=CC2=CC=CC=C21)NC3CCN(C3)C4=CC=C(C=C4)CC(=O)O
2.1.5 Isomeric SMILES
C[C@H](C1=CC=CC2=CC=CC=C21)N[C@H]3CCN(C3)C4=CC=C(C=C4)CC(=O)O
2.2 Other Identifiers
2.2.1 UNII
E58MLH082P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (4-((3s)-3-(((1r)-1-(1-naphthyl)ethyl)amino)-1-pyrrolidinyl)phenyl)acetic Acid

2.3.2 Depositor-Supplied Synonyms

1. 870964-67-3

2. Evocalcet [inn]

3. Mt-4580

4. Khk-7580

5. Khk7580

6. E58mlh082p

7. 4-[(3s)-3-[[(1r)-1-(1-naphthalenyl)ethyl]amino]-1-pyrrolidinyl]benzeneaceticacid

8. 2-[4-[(3s)-3-[[(1r)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic Acid

9. 4-[(3s)-3-[[(1r)-1-(1-naphthalenyl)ethyl]amino]-1-pyrrolidinyl]benzeneacetic Acid

10. Benzeneacetic Acid, 4-((3s)-3-(((1r)-1-(1-naphthalenyl)ethyl)amino)-1-pyrrolidinyl)-

11. 2-(4-((s)-3-(((r)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetic Acid

12. 2-[4-[(3s)-3-[[(1r)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]ethanoic Acid

13. Unii-e58mlh082p

14. Evocalcet?

15. H43

16. Orkedia (tn)

17. Evocalcet (jan/inn)

18. Evocalcet [jan]

19. Evocalcet [mi]

20. Evocalcet [who-dd]

21. Gtpl9042

22. Chembl4297621

23. Schembl14668291

24. Khk7580khk7580

25. Dtxsid101132784

26. Vjb96467

27. Akos040741717

28. Db12388

29. Khk7580; Mt-4580

30. Hy-17613

31. Ms-26062

32. Cs-0014698

33. Ns00073438

34. D11063

35. G15959

36. Q27077250

37. (4-((3s)-3-(((1r)-1-(1-naphthyl)ethyl)amino)-1-pyrrolidinyl)phenyl)acetic Acid

2.4 Create Date
2013-03-21
3 Chemical and Physical Properties
Molecular Weight 374.5 g/mol
Molecular Formula C24H26N2O2
XLogP32.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area52.6
Heavy Atom Count28
Formal Charge0
Complexity517
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

H - Systemic hormonal preparations, excl. sex hormones and insulins

H05 - Calcium homeostasis

H05B - Anti-parathyroid agents

H05BX - Other anti-parathyroid agents

H05BX06 - Evocalcet


API SUPPLIERS

read-more
read-more

01

Shandong Loncom Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shandong Loncom Pharmaceutical company banner

02

Mitsubishi Tanabe Pharma

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

Mitsubishi Tanabe Pharma

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

03

ATK Chemical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

ATK Chemical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

KareBay Biochem

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

KareBay Biochem

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

J&H CHEM

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

J&H CHEM

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Sichuan Qingmu Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Kyowa Kirin

Japan
SupplySide West 2024
Not Confirmed
arrow

Kyowa Kirin

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Brand Name : Orkedia

Dosage Form : Tablet

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Japan

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Kyowa Kirin

Japan
SupplySide West 2024
Not Confirmed
arrow

Kyowa Kirin

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Brand Name : Orkedia

Dosage Form : Tablet

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Japan

blank

01

Kyowa Kirin

Japan
SupplySide West 2024
Not Confirmed
arrow

Kyowa Kirin

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Dosage : Tablet

Dosage Strength : 4MG

Brand Name : Orkedia

Approval Date :

Application Number :

Registration Country : Japan

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

read-more
read-more

01

Brand Name : Orkedia

Evocalcet

arrow
SupplySide West 2024
Not Confirmed

Brand Name : Orkedia

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2020 Revenue in Millions : 86

2019 Revenue in Millions : 65

Growth (%) : 32

blank

02

Brand Name : Orkedia

Evocalcet

arrow
SupplySide West 2024
Not Confirmed

Brand Name : Orkedia

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2021 Revenue in Millions : 84

2020 Revenue in Millions : 86

Growth (%) : 9

blank

03

Brand Name : Orkedia

Evocalcet

arrow
SupplySide West 2024
Not Confirmed

Brand Name : Orkedia

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Main Therapeutic Indication : Endocrinology

Currency : USD

2022 Revenue in Millions : 78

2021 Revenue in Millions : 84

Growth (%) : -7

blank

04

Brand Name : Orkedia

Evocalcet

arrow
SupplySide West 2024
Not Confirmed

Brand Name : Orkedia

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Main Therapeutic Indication : Endocrinology

Currency : USD

2023 Revenue in Millions : 71

2022 Revenue in Millions : 78

Growth (%) : 3

blank

05

Brand Name : Orkedia

Evocalcet

arrow
SupplySide West 2024
Not Confirmed

Brand Name : Orkedia

Japan
arrow
SupplySide West 2024
Not Confirmed

Evocalcet

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2019 Revenue in Millions : 64

2018 Revenue in Millions : 22

Growth (%) : 188

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty